WooGene B&G Co., Ltd (KOSDAQ:018620)

South Korea flag South Korea · Delayed Price · Currency is KRW
852.00
-6.00 (-0.70%)
At close: Mar 25, 2025, 3:30 PM KST
-25.78%
Market Cap 24.84B
Revenue (ttm) 58.64B
Net Income (ttm) 1.24B
Shares Out 28.89M
EPS (ttm) 42.95
PE Ratio 20.02
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 74,825
Average Volume 57,543
Open 858.00
Previous Close 858.00
Day's Range 840.00 - 862.00
52-Week Range 830.00 - 1,216.00
Beta 0.72
RSI 39.58
Earnings Date Mar 21, 2025

About WooGene B&G

WooGene B&G Co., Ltd. engages veterinary medicines, microbial technology, and vaccines business in South Korea and internationally. It offers antibiotic, vaccine, nutrient, anti-inflammation, metabolic stimulant, and iron supplement products for swine, poultry, cattle, aquatic animals, companion animals, and raw materials, as well as operates vaccine research center. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Hw... [Read more]

Industry Pharmaceutical Preparations
Founded 1977
Employees 84
Stock Exchange KOSDAQ
Ticker Symbol 018620
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.